|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$81,901.85 |
2.80% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$80,118.80 |
2.74% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$75,013.80 |
2.57% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$74,372.80 |
2.54% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$73,064.97 |
2.50% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$72,152.45 |
2.47% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$70,649.44 |
2.42% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$69,357.60 |
2.37% |
| Waters Corporation |
WAT |
941848103 |
184 |
$69,255.76 |
2.37% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$68,264.52 |
2.34% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$68,198.13 |
2.33% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$66,802.89 |
2.29% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$65,767.83 |
2.25% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$64,819.68 |
2.22% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$64,391.87 |
2.20% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$63,506.42 |
2.17% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$63,067.01 |
2.16% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$63,020.26 |
2.16% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$62,949.74 |
2.15% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$61,705.50 |
2.11% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$61,361.28 |
2.10% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$61,398.72 |
2.10% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$60,676.40 |
2.08% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$60,400.47 |
2.07% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$59,167.35 |
2.02% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$57,548.30 |
1.97% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$57,621.99 |
1.97% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$56,726.28 |
1.94% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,294.28 |
1.93% |
| Steris Plc |
STE |
G8473T100 |
265 |
$55,313.45 |
1.89% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$54,475.38 |
1.86% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$54,126.18 |
1.85% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$53,606.80 |
1.83% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$53,123.49 |
1.82% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$52,308.48 |
1.79% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$52,444.60 |
1.79% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$52,162.22 |
1.78% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$51,113.18 |
1.75% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$50,621.04 |
1.73% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$50,300.04 |
1.72% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$49,759.62 |
1.70% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$49,796.58 |
1.70% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$49,434.64 |
1.69% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$49,335.00 |
1.69% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$47,736.00 |
1.63% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$46,346.16 |
1.59% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$44,735.85 |
1.53% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$41,582.15 |
1.42% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$40,711.65 |
1.39% |
| US Dollar |
$USD |
|
14,464 |
$14,464.20 |
0.49% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|